MedTrace Logo

Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness

NCT01816607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 192

Last updated 2018-11-19

No results posted yet for this study

Summary

The purpose of this study is to establish a reliable method for detection of rectal cancer patients with aggressive tumor at risk of metastatic disease and death by functional MRI.

Conditions

  • Rectal Diseases
  • Rectal Neoplasms
  • Gastrointestinal Diseases
  • Gastrointestinal Neoplasms

Interventions

PROCEDURE

new functional magnetic resonance imaging (MRI) protocols

diffusion-weighted MRI, dynamic-contrast enhanced MRI, MR spectroscopy, blood-level oxygen dependent (BOLD) MRI

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Kathrine Røe Redalen, PhD · University Hospital, Akershus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816607 on ClinicalTrials.gov